浙江醫藥(600216.SH):新碼生物擬引進戰略投資者增資4.15億元
格隆匯 3 月 18日丨浙江醫藥(600216.SH)公佈,公司、公司下屬子公司浙江新碼生物醫藥有限公司(“新碼生物”、“目標公司”)、新碼生物下屬子公司Novocodex,Inc.和新碼生物創始人梁學軍、夏鋼與蘇州禮康股權投資中心(有限合夥)、禮安新紹有限公司(LAV Novo Hong Kong Limited)、杭州創乾投資合夥企業(有限合夥)、先進製造產業投資基金二期(有限合夥)、杭州三花弘道創業投資合夥企業(有限合夥)、紹興越明生物醫藥合夥企業(有限合夥)、廣州新澤資本管理合夥企業(有限合夥)、張少波及其他原股東擬簽署《關於浙江新碼生物醫藥有限公司之增資協議》及《關於浙江新碼生物醫藥有限公司之股東協議》,協議約定以4.15億元人民幣或等值美元的增資款對目標公司進行增資,並認購目標公司的新增註冊資本556.1萬元人民幣(剩餘的增資款計入目標公司的資本公積),取得增資後目標公司約23.512748%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.